Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Bulk Drug Intermediates >  2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one

2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one

Basic information Safety Supplier Related

2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one Basic information

Product Name:
2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one
Synonyms:
  • 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one
  • 2-Bromo-8-fluoro-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
  • Rucaparib int
  • 3-cd]indol-6(3H)-one
  • 5-bromo-8-fluoro-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one
  • 5-bromo-8-fluoro-3,4-dihydro-2H- azepino[5,4,3-cd]indol-1(6H)-one
  • 2-bromo-8-fluoro-4
  • 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-on
CAS:
283173-80-8
MF:
C11H8BrFN2O
MW:
283.1
EINECS:
1592732-453-0
Mol File:
283173-80-8.mol
More
Less

2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one Chemical Properties

Boiling point:
571.4±50.0 °C(Predicted)
Density 
1.751±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
13.53±0.20(Predicted)
More
Less

2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one Usage And Synthesis

Synthesis

1408282-26-7

283173-80-8

8-Fluoro-4,5-dihydro-1H-azabino[5,4,3-cd]indol-6(3H)-one (10 g, 49.0 mmol) was used as a feedstock and suspended in a 1 L reactor at room temperature with 225 mL of a dichloromethane/tetrahydrofuran solvent mixture (1:3, v/v). The resulting suspension was cooled to 5 °C with stirring, followed by dropwise addition of a tetrahydrofuran solution of pyridinium tribromide (17.22 g, 53.9 mmol, dissolved in 75 mL of tetrahydrofuran). The reaction temperature was maintained at 5 °C and stirred continuously for 2 h until the reaction was complete. After completion of the reaction, 100 mL of water was added to give a clarified orange solution. The solution was concentrated under reduced pressure until crystals began to precipitate. Next, 750 mL of saturated sodium carbonate solution was added and the mixture was stirred at room temperature for 1 hour to form a suspension. The crystals were collected by filtration, washed with 100 mL of water, and subsequently dried in a vacuum oven at 55 °C for 4 h. 11.3 g of the target product, 2-bromo-8-fluoro-4,5-dihydro-1H-azabino[5,4,3-cd]indol-6(3H)-one, was finally obtained.

References

[1] Organic Process Research and Development, 2012, vol. 16, # 12, p. 1897 - 1904
[2] ACS Chemical Neuroscience, 2018, vol. 9, # 6, p. 1259 - 1263
[3] Patent: WO2018/140377, 2018, A1. Location in patent: Paragraph 00323

2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-oneSupplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn
Shanghai Feibo Chemical Technology Co., Ltd
Tel
021-58955608,2250286 15921236618
Email
blinkzeng@gmail.com
Synches Co., Ltd.
Tel
021-53292253
Email
biz@synches.com
T&W GROUP
Tel
021-61551611 13296011611
Email
contact@trustwe.com